Phathom Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Phathom Pharmaceuticals

10/05/2023 13:47

* Phathom Pharmaceuticals Inc  PHAT.OQ  reported a quarterly
adjusted loss of 89 cents​​ per share for the quarter ended in
March. The mean expectation of six analysts for the quarter was
for a loss of $1.26 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Phathom Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 89 cents​.
    * The mean earnings estimate of analysts had risen by
about 12.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Phathom Pharmaceuticals Inc shares had risen by 67.9% this
quarter and gained 6.9% so far this year.
    * The company reported a quarterly loss of $37.81 million.
    * Wall Street's median 12-month price target for Phathom
Pharmaceuticals Inc is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 12:47 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -1.26          -0.89          Beat
 Dec. 31 2022      -1.35          -1.33          Beat
 Sep. 30 2022      -1.32          -1.32          Met
 Jun. 30 2022      -1.03          -1.33          Missed